Vaccine Development: the Business Case and the Public Health Imperative

Event Date: January 19, 2011

During this outstanding event we heard from a distinguished panel of speakers about the business case for vaccines and the alignment with the public health imperative. We explored the complex issues of vaccine investment and development, including research, legal, and regulatory challenges with:

• Gus Birkhead, MD, MPH – Deputy Commissioner, NY State Dept of Health
• Douglass Given, MD, PhD, MBA- Chairman of Vivaldi Biosciences (a new start-up vaccine company incubated in NYC) and Partner, Bay City Capital
• John Grabenstein, RPh, PhD - Senior Medical Director for Adult Vaccines, Merck Vaccines
• Peter Paradiso, PhD – Vice President, New Business and Scientific Affairs, Pfizer Vaccines
• Jane Zucker, MD, MSc – Assistant Commissioner, Bureau of Immunization of New York City Department of Health and Mental Hygiene